Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi lung cancer drug fails in late-stage trial

March 11, 2011
Research and Development Cancer, NSCLC, Regeneron, Sanofi-Aventis, aflibercept, non-small cell lung cancer

Sanofi-Aventis’ lung cancer drug aflibercept has failed to meet its primary endpoint in a phase III trial. The late-stage VITAL …

News

UK dementia awareness campaign launched

March 11, 2011
Medical Communications dementia, disease awareness, disease awareness campaigns, stroke

The Department of Health has launched a £1.2 million awareness campaign which aims to alert people to the early signs …

News

Tangles and plaques: unlocking the secrets of Alzheimer’s disease

March 11, 2011
Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, bapineuzumab, dimebon, latrepirdine, solanezumab

Despite many years of relentless research efforts, Alzheimer’s disease, the most common form of dementia, remains impossible to cure. According …

Feature

NICE stands firm on Tarceva

March 11, 2011
Cancer, NICE, Roche, Tarceva, erlotinib

NICE has not recommended Roche’s lung cancer drug Tarceva because its effectiveness as a maintenance therapy remains unclear. NICE is …

News
systemic lupus erythematosus (SLE)

US approval for GSK’s lupus treatment Benlysta

March 10, 2011
Sales and Marketing Benlysta, GSK, GlaxoSmithKline, Human Genome Sciences, Lupus, belimumab, systemic lupus erythematosus

GlaxoSmithKline’s lupus treatment Benylsta has won an historic approval in the US, but will have to prove its safety record …

News

Matthew Kent moves to 90TEN Healthcare

March 10, 2011
Medical Communications 90Ten Healthcare, Matthew Kent, appointment, medical communications

90TEN Healthcare has appointed Matthew Kent as an associate director and to its senior management team. He joins the company …

Appointment

New skills and ways of working in healthcare comms

March 10, 2011
Medical Communications HCA, Healthcare Communications Association, benchmarking

A new report from the Healthcare Communications Association (HCA) indicates a trend towards new skills and ways of working, as …

Feature

Novartis’ COPD drug recommended for FDA approval

March 10, 2011
Sales and Marketing Arcapta Neohaler, COPD, Novartis, Onbrez Breezhaler, QAB143, chronic obstructive pulmonary disease, indacterol

Novartis has won the backing of an FDA advisory committee for its chronic obstructive pulmonary disease (COPD) treatment QAB149. The …

News

‘This R&D Malarkey, it’s broken, isn’t it?’

March 9, 2011
Research and Development R&D, Sandwich, research productivity

Pharmaceutical industry leaders are increasingly admitting that the very low productivity of its R&D pipelines is unsustainable – but no …

Feature

Francois Meyer to head up TxCell

March 9, 2011
Research and Development Francois Meyer, TxCell, appointment, research and development

French biotech TxCell has appointed François Meyer as chief executive. He has more than 25 years of pharma and biotech …

Appointment

Janssen’s monthly antipsychotic approved in Europe

March 9, 2011
Sales and Marketing Janssen, Xeplion, antipsychotic, injectible antipsychotic, paliperidone palmitate, schizophrenia

Janssen’s injectable antipsychotic Xeplion has been approved by the European Commission for the treatment of schizophrenia. There is no cure …

News

Actelion defends itself against investor aggression

March 9, 2011
Sales and Marketing Actelion, Tracleer, almorexant

Swiss biotech firm Actelion is mounting a defence of its management board and strategy following an offensive by a shareholder …

News

Finance a bigger worry than reform for NHS chiefs

March 9, 2011
Acute Trusts, NHS, NHS Confederation, NHS finances, NHS reforms

NHS leaders are more concerned with how they are going to balance the books this year than with the reorganisation …

News
AstraZeneca

AZ partners with Galderma on psoriasis research

March 9, 2011
Research and Development AZ, AstraZeneca, Galderma, dermatology, psoriasis

AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …

News

Health secretary defends NHS reform to doctors

March 8, 2011
GP consortia, Health and Social Reform bill, NHS, NHS reforms

Health secretary Andrew Lansley has defended his reorganisation of the NHS to doctors, saying it will cut unnecessary levels of …

News

Eisai confirms 20% cut in US workforce

March 8, 2011
Manufacturing and Production, Research and Development, Sales and Marketing Aricept, Eisai, Halaven, US, donepezil, eribulin, pharma job cuts

Eisai’s planned job cuts will fall heaviest on its US operations, where 20% of the workforce will be let go …

News

Sophie Gibbs and Naumaan Mayet join Pan

March 8, 2011
Medical Communications, Sales and Marketing Naumaan Mayet, Pan, Pan Advertising, Sophie Gibbs, appointment, medical communications

Pan Advertising has recruited two new members to its account handling team.Sophie Gibbs returns to the agency as an account …

Appointment
Merck & Co workers protest job cuts

Merck says sale of Oss facility would be too expensive

March 8, 2011
Manufacturing and Production, Research and Development Holland, Merck & Co, Oss, Oss pharma research, Pantarhei Bioscience

The debate around the closure of Merck & Co’s R&D and manufacturing unit in Oss, the Netherlands, rumbles on, with …

News

AZ stops making Pulmicort pMDI inhaler

March 8, 2011
Manufacturing and Production AZ, AstraZeneca, Pulmicort, Pulmicort pMDI, Skyepharma, asthma, asthma inhaler, budesonide

AstraZeneca has discontinued production of its Pulmicort pMDI asthma inhaler because of manufacturing issues, and looks set to exit from …

News

Helsinn expands high-potency plant with cytotoxics suite

March 8, 2011
Manufacturing and Production APIs, CMOs, GMP, Helsinn, Helsinn Advanced Synthesis, Swiss pharma contract manufacturing, contract manufacturing, high-potency APIs

Helsinn is on track to complete construction of a new manufacturing plant for cytotoxic active pharmaceutical ingredients in Biasca, Switzerland, …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026